Editorial
doi: 10.1016/j.jacc.2014.02.546.
Epub 2014 Mar 19.
Shared risk factors for anticoagulation in nonvalvular atrial fibrillation: a dilemma in clinical decision making
Affiliations
- PMID: 24657689
- DOI: 10.1016/j.jacc.2014.02.546
Item in Clipboard
Editorial
Shared risk factors for anticoagulation in nonvalvular atrial fibrillation: a dilemma in clinical decision making
J Am Coll Cardiol.
.
Free article
No abstract available
Keywords: atrial fibrillation; bleeding; factor Xa inhibitor.
Comment on
-
Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.J Am Coll Cardiol. 2014 May 27;63(20):2141-2147. doi: 10.1016/j.jacc.2014.02.549. Epub 2014 Mar 19. J Am Coll Cardiol. 2014. PMID: 24657685 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
